Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2022

Filter by date:

Showing 1107 press releases before 2022

AstraZeneca provides update on MYSTIC trial timeline
12 March 2018
New data from landmark CVD-REAL study of patients with type-2 diabetes confirms CV benefits associated with SGLT-2 Inhibitors
12 March 2018
The European Medicines Agency accepts regulatory submission for Forxiga in adults with type-1 diabetes
5 March 2018
AstraZeneca aims to advance clinical practice in CV risk management with new data at ACC 2018
5 March 2018
MedImmune to create stand-alone company for early-stage inflammation and autoimmunity biologics
28 February 2018
Lynparza receives positive EU CHMP opinion in platinum-sensitive relapsed ovarian cancer
23 February 2018
US FDA approves Imfinzi for unresectable Stage III non-small cell lung cancer
19 February 2018
Selumetinib granted Orphan Drug Designation by the US FDA for neurofibromatosis type 1
15 February 2018
Brilinta significantly reduces CV events and coronary death beyond one year in heart attack survivors with multi-vessel disease
7 February 2018
Full-Year 2017 Results
2 February 2018

<
1
2
3
111
>

All of our latest press releases and articles are available to explore